Clinical Evaluation of the Integra® Titan™ Modular Shoulder System Generation 2.5 for Primary Shoulder Joint Replacement



Status:Recruiting
Conditions:Arthritis, Osteoarthritis (OA), Rheumatoid Arthritis
Therapuetic Areas:Rheumatology
Healthy:No
Age Range:18 - Any
Updated:1/27/2019
Start Date:August 1, 2017
End Date:April 1, 2029
Contact:Andrew Tummon
Email:andrew.tummon@integralife.com
Phone:(+1) 609-936-5490

Use our guide to learn which trials are right for you!

A Post-Market, Prospective, Multi-Center, Open-Label, Single Arm Clinical Evaluation of the Integra® Titan™ Modular Shoulder System Generation 2.5 for Primary Shoulder Joint Replacement

A post market, prospective, non-randomized, multi-center, open-label, clinical study using
survivorship as the reference performance goal to study the safety and efficacy of the Titan
Modular Shoulder System 2.5 when used for primary shoulder arthroplasty.


Inclusion Criteria:

- For total shoulder arthroplasty, subjects must meet a, b, or c below:

1. Severely painful and/or disabled joint resulting from osteoarthritis, traumatic
arthritis or rheumatoid arthritis

2. Fracture-dislocations of the proximal humerus where the articular surface is
severely comminuted, separated from its blood supply or where the surgeon's
experience indicates that alternative methods of treatment are unsatisfactory

3. Other difficult clinical problems where shoulder arthrodesis or resection
arthroplasty are not acceptable (e.g. -revision of a failed primary component)

- For shoulder hemiarthroplasty, subjects must meet any of the sub-criteria a - g below:

1. Severely painful and/or disabled joint resulting from osteoarthritis, traumatic
arthritis or rheumatoid arthritis

2. Fracture-dislocations of the proximal humerus where the articular surface is
severely comminuted, separated from its blood supply or where the surgeon's
experience indicates that alternative methods of treatment are unsatisfactory

3. Other difficult clinical problems where shoulder arthrodesis or resection
arthroplasty are not acceptable (e.g. -revision of a failed primary component)

4. Ununited humeral head fractures

5. Avascular necrosis of the humeral head

6. Rotator cuff arthropathy

7. Deformity and/or limited motion

Exclusion Criteria:

- Absent, irreparable or nonfunctional rotator cuff or other essential muscles.

- Have an active local or systemic infection.

- Have inadequate bone stock in the proximal humerus or glenoid fossa for supporting the
components.

- Have poor bone quality such as osteoporosis where there could be considerable
migration of the prosthesis and/or a chance of fracture of the humerus or glenoid.

- Have a muscular, neurologic, or vascular deficiencies that compromise the affected
extremity.

- Have a known sensitivity or allergic reaction to one or more of the implanted
materials.

- Have a condition that may impair proper wound healing.
We found this trial at
7
sites
1215 Lee St
Charlottesville, Virginia 22903
(434) 924-0211
University of Virginia Health System UVA Health System includes a 604-bed hospital, level I trauma...
?
mi
from
Charlottesville, VA
Click here to add this to my saved trials
3400 Spruce St
Philadelphia, Pennsylvania 19104
 (215) 662-4000
Hospital of the University of Pennsylvania The Hospital of the University of Pennsylvania (HUP) is...
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Columbia, Maryland 21044
?
mi
from
Columbia, MD
Click here to add this to my saved trials
Lancaster, Pennsylvania 17601
?
mi
from
Lancaster, PA
Click here to add this to my saved trials
New Albany, Ohio 43054
?
mi
from
New Albany, OH
Click here to add this to my saved trials
Philadelphia, Pennsylvania 19107
Phone: 267-339-3615
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Starkville, Mississippi 39759
?
mi
from
Starkville, MS
Click here to add this to my saved trials